Casio to Release Automatic Mechanical EDIFICE with a Look That Changes with the Light

Casio to Release Automatic Mechanical EDIFICE with a Look That Changes with the Light

Case Design Showcases Refined Curves and Finishes TOKYO, June 30, 2026 /PRNewswire/ -- Casio Computer Co., Ltd. announced today the release of the latest addition to the EDIFICE line of timepieces. The new EFK-200 with automatic mechanical movement...

DIMERIX EXCLUSIVELY LICENSES DMX-200 IN GREATER CHINA, SOUTH KOREA AND SOUTHEAST ASIA TO EVEREST MEDICINES

DIMERIX EXCLUSIVELY LICENSES DMX-200 IN GREATER CHINA, SOUTH KOREA AND SOUTHEAST ASIA TO EVEREST MEDICINES

Everest Medicines licenses exclusive rights to commercialise DMX-200 for the treatment of Focal Segmental Glomerulosclerosis (FSGS) in Greater China, South Korea and Southeast Asia 500,000-1 million people are estimated to be living with FSGS in the...

ProPak China 2026 - 200,000 sqm Premier Processing & Packaging Event Opens This June

ProPak China 2026 - 200,000 sqm Premier Processing & Packaging Event Opens This June

SHANGHAI, May 26, 2026 /PRNewswire/ -- ProPak China 2026, the 31st International Processing and Packaging Exhibition, is scheduled to be held at the National Exhibition and Convention Center (NECC, Shanghai) from June 15 to 17, 2026. Organized by...

Power Guarantee Accelerates Commissioning of Jinchang's 200,000-Ton Dairy Processing Project

Power Guarantee Accelerates Commissioning of Jinchang's 200,000-Ton Dairy Processing Project

JINCHANG, China, April 29, 2026 /PRNewswire/ -- On April 22, State Grid Jinchang Power Supply Company worked with relevant personnel of the 200,000-ton annual dairy processing project in Jinchuan District, Jinchang City, to carefully verify key...

BLINDED ASSESSMENT OF ACTION3 STATISTICAL ASSUMPTIONS COMPLETE

BLINDED ASSESSMENT OF ACTION3 STATISTICAL ASSUMPTIONS COMPLETE

Key Highlights: An external statistical blinded review of ACTION3 data has achieved its objective by confirming that the study remains appropriately statistically powered (>90%) to demonstrate a treatment effect for the primary study endpoint of...

Marvion Inc. Enters $200,000 Stock Purchase Agreement to Strengthen Capital Base and Support Strategic Growth

Marvion Inc. Enters $200,000 Stock Purchase Agreement to Strengthen Capital Base and Support Strategic Growth

HONG KONG, Jan. 19, 2026 /PRNewswire/ -- Marvion Inc. (OTCQB: MVNC) (the "Company" or "Marvion") announced today that it has entered into a stock purchase agreement with third-party investor Ray Mak Pak Fai (the "Investor"). Under the agreement, the...

Last Chance Year-End Deals from Singapore: Fly T'way Air to Korea

Last Chance Year-End Deals from Singapore: Fly T'way Air to Korea

Exclusive Offers for Seoul and Jeju; Flexible Travel through Mar/Oct 2026 SINGAPORE, Dec. 18, 2025 /PRNewswire/ -- T'way Air, Korea's leading low-cost carrier, announced year-end savings for travel to Korea, with a limited-time promo code and...

DMX-200 ACTION3 PHASE 3 TRIAL COMPLETES RECRUITMENT

DMX-200 ACTION3 PHASE 3 TRIAL COMPLETES RECRUITMENT

Recruitment successfully completed in Dimerix' ACTION3 Phase 3 clinical trial[1], which has recruited and dosed its target 286th adult patient The ACTION3 Phase 3 trial explores the efficacy and safety of DMX-200 in FSGS patients when dosed in...

Air France expands network with a new non-stop service between Phuket and Paris

Air France expands network with a new non-stop service between Phuket and Paris

PHUKET, Thailand, Dec. 1, 2025 /PRNewswire/ -- Air France has officially inaugurated a new 3 weekly non-stop flight between Phuket and Paris on 28 November 2025. Air France arrival in Phuket Air France will operate the 3 flights every Tuesday,...

ToolGen and GenEditBio Enter Strategic Cross-License Agreement to Accelerate Development of Innovative Genome-Editing Therapeutics

ToolGen and GenEditBio Enter Strategic Cross-License Agreement to Accelerate Development of Innovative Genome-Editing Therapeutics

Integrates ToolGen's best-in-class CRISPR-Cas9 platform with GenEditBio's industry-leading lipid nanoparticle (LNP) delivery technology Pursues a "once-and-done" treatment paradigm for diseases with high unmet medical needs SEOUL, South Korea, Nov....

  • 1
  • 2
  • 3
  • menu
    menu